INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Building A Global Cell And Gene Supply Chain Serving Personalized Medicine

  Clinical distribution paths can be fragile for a multitude of reasons, making it critical that pharmaceutical sponsors and their partners orchestrate supply chain logistics even before site initiation.

• SUS Assurance: Improving Supply Chain Management

  Locking in the supply to support crucial production components in a landscape beset with unprecedented demand requires cross-functional, collaborative solutions from the industry’s biggest players.

• Enabling Fast, Appropriate Drug Product Supply For Phase 1 Trials

  Without the ability to move smoothly from lab concept to manufacture to delivery of GMP clinical supplies to patients, critical milestones could be missed, delaying funding commitments from investors.

• Supporting The Global Biopharma Industry With Single-Use Capacity Expansion

  Explore Cytiva’s brand new single-use production facility in Wales, UK. This facility forms part of Cytiva’s >$1.5 billion investment in increased capacity to support the growing needs of the biopharmaceutical industry and to increase regional supply.

• 2022 Cold Chain Predictions: Creating A New Normal

  12/17/2021

  While COVID-19’s influence persists, we see renewed interest in sustainability and the evolving impact of Brexit’s export regulations, which will shape how the pharma and cold chain industries operate.

• Validation Of Integrated Cryogenic Systems For Cell Therapy Manufacturing

  4/13/2021

  Amittha Wickrema, Ph.D., Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, University of Chicago, reviews the cold chain workflow from start to finish for a cellular therapy product.

• The CDMO Of The Future: Supply Chain Secure

  9/1/2021

  Future-ready CDMOs are making the technology and facility investments needed to further transform supply chain security, and are already pursuing initiatives that will support cost optimization and enhance supply chain agility as a competitive advantage.

• Navigating The Adoption Of Continuous Pharma Manufacturing

  3/1/2021

  Driving a path forward for continuous manufacturing calls for a closer look at current global challenges, any existing barriers, and the ideas and initiatives necessary to fulfill its potential.

• Bulletproof Supply Chain: Hope For The Best, Prepare For The Worst

  8/3/2021

  How to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how a risk-based approach can determine where a contingency plan is needed.